Literature DB >> 4598113

Reversal of ouabain and acetyl strophanthidin effects in normal and failing cardiac muscle by specific antibody.

H K Gold, T W Smith.   

Abstract

Isolated cat right ventricular papillary muscles were used to study the effects of antibodies with high affinity for ouabain and acetyl strophanthidin on myocardium exposed to these cardioactive steroids. Antibodies with average intrinsic affinity constants for ouabain and acetyl strophanthidin of the order of 10(8) M(-1) were raised in rabbits challenged by repeated injection of a conjugate of ouabain covalently linked to a poly D,L-alanyl derivative of human serum albumin. Effects were assessed in terms of time-course and extent of inotropy reversal, influence of experimentally induced ventricular failure, digitalis-antibody concentration relations, influence of digitalis-antibody complex on response to additionally added digitalis, and relation of antibody effects on digitalis-induced automaticity and contracture to reversal of inotropy. Specific antibody (but not control antibody) in 1.1-1.5-fold molar excess over cardioactive steroid concentrations blocked positive inotropic effects of ouabain and acetyl strophanthidin, and gradually reversed established contractile effects of these agents with a mean time for half-reversal of ouabain-induced inotropy of 124+/-6 (SEM) min and 37+/-3 min for half-reversal of acetyl strophanthidin-induced inotropy. Papillary muscles from cats with right ventricular failure induced by chronic pulmonary artery constriction responded similarly. Both normal and failing muscles returned to but not below levels of contractility existing before cardioactive steroid exposure, and time for half-reversal of inotropy by antibody was significantly shorter than time for half-reversal after removal of ouabain or acetyl strophanthidin by muscle bath washout alone. Presence of ouabain- or acetyl strophanthidin-antibody complex did not alter the myocardial contractile response to subsequently added cardioactive steroids. Spontaneous automaticity occurring as a toxic response to ouabain or acetyl strophanthidin in eight muscles was rapidly reversed by specific antibody at a time when positive inotropic effects were still fully manifest. Early contracture was also reversed by specific antibody. These studies provide further support for the concept that cardiac glycoside-specific antibodies are capable of reversing established cellular effects of cardioactive steroids.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4598113      PMCID: PMC302661          DOI: 10.1172/JCI107716

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin.

Authors:  T W Smith; V P Butler; E Haber
Journal:  Biochemistry       Date:  1970-01-20       Impact factor: 3.162

2.  Digoxin-specific antibodies.

Authors:  V P Butler; J P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1967-01       Impact factor: 11.205

Review 3.  The subcellular basis for the mechanism of inotropic action of cardiac glycosides.

Authors:  K S Lee; W Klaus
Journal:  Pharmacol Rev       Date:  1971-09       Impact factor: 25.468

4.  Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure.

Authors:  J F Spann; R A Buccino; E H Sonnenblick; E Braunwald
Journal:  Circ Res       Date:  1967-09       Impact factor: 17.367

5.  Effects of experimental heart failure on the capacity of glucagon to augment myocardial contractility and activate adenyl cyclase.

Authors:  H K Gold; K H Prindle; G S Levey; S E Epstein
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

6.  Biologic activity of digoxin-specific antisera.

Authors:  J F Watson; V P Butler
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

7.  Reversal of digoxin toxicity with specific antibodies.

Authors:  D H Schmidt; V P Butler
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

8.  The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin.

Authors:  J Curd; T W Smith; J C Jaton; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

9.  Immunological protecion against dixin toxicity.

Authors:  D H Schmidt; V P Butler
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

10.  The mechanochemistry of cardiac muscle. I. The isometric contraction.

Authors:  P E Pool; E H Sonnenblick
Journal:  J Gen Physiol       Date:  1967-03       Impact factor: 4.086

View more
  5 in total

1.  Monoclonal antibodies to T-2 toxin. In vitro neutralization of protein synthesis inhibition and protection of rats against lethal toxemia.

Authors:  G Feuerstein; J A Powell; A T Knower; K W Hunter
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

2.  Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.

Authors:  H R Ochs; T W Smith
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

3.  Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.

Authors:  T W Smith; B L Lloyd; N Spicer; E Haber
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

4.  Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.

Authors:  V P Butler; D H Schmidt; T W Smith; E Haber; B D Raynor; P Demartini
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

5.  Extracellular versus intracellular digoxin action on bovine myocardium, using a digoxin antibody and intracellular glycoside application.

Authors:  P Hess; P Müller
Journal:  J Physiol       Date:  1982-01       Impact factor: 5.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.